Raymond James analyst Laura Prendergast downgraded Mural Oncology (MURA) to Outperform from Strong Buy with an $18 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
